Non-Hodgkin's lymphoma (NHL) involving the endobronchial tree is uncommon, and the initial presentation of NHL as an endobronchial tumor is extremely rare. Several clinical reports have described bronchial-associated lymphoid tissue (BALT) lymphoma as an endobronchial lesion.
INTRODUCTION
Non-Hodgkin's lymphoma (NHL) involving the endobronchial tree is uncommon. 13 It is rare for an endobronchial lesion to be the primary presentation
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Dr Manoj K Goel Director, Delhi Heart & Lung Institute 3MM-ll Panchkuian Road, New Delhi -110055 Tel: 011-42999999 EXN: 6054, Fax: 011-23514489 E-mail: drgoelmanoj@yahoo.co.in of lymphoma, comprising <1%of all NHL. Endobronchial lymphoma is classifi ed into two types, according to pattern of involvement. Type 1 includes diffuse submucosal infi ltrates originating from hematogenous or lymphangitic spread in the presence of systemic lymphoma. Type II (similar to our patient) includes airway involvement by a localized mass due to direct spread of lymphoma from adjacent lymph nodes or arising de novo from bronchus-associated lymphoid tissue (BALT). The differential diagnosis of BALT lymphoma includes reactive lymphoid conditions such as intrapulmonary lymph node, lymphoid hyperplasia, follicular bronchitis and interstitial lymphoid hyperplasia. Overall, the 5-year survival is over 80% and the median survival time is greater than 10 years.
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Case Summary
A 77 year old male hospitalized in another hospital for acute breathlessness and mechanically ventilated. He was shifted to Delhi Heart And Lung Institute because of failed extubation after 3 days of mechanical ventilation and reintubated. Past History of intubation was present 1 month back and diagnosed as a case of acute bronchitis He was conscious, oriented comprehending verbal commands. On evaluation at another hospital, the patient was found to have normal chest radiograph. At admission, the patient was afebrile, had endotracheal tube in situ, heart rate 109/min and a respiratory rate18 /min. There was no pallor, clubbing, lymphadenopathy or pedal oedema. Chest examination revealed fi ndings consistent assisted ventilatory breath sounds associated with bilateral ronchi. The rest of systemic examination was unremarkable. On investigation, hemoglobin, arterial blood gases levels, blood counts and metabolic parameters were within normal limits. Sputum smear examination by Gram's and ZiehlNeelsen's stains was negative.
Chest radiograph showed normal study ( Figure  1 ). Contrast enhanced computed tomography of the chest revealed endoluminal soft tissue mass lesion at carina signifi cantly obliterating bilateral main bronchi (Figure 2 Histopathological examination of the endobronchial biopsy showed tumor cells have a round or oval nucleus that appears vesicular because of margination of chromatin at the nuclear membrane, but large multilobed or cleaved nuclei predominate in some cases( Figure 5 ) .Nucleoli may be 2-3 in number and located adjacent to the nuclear membrane, or they may be single and centrally placed. Cytoplasm is usually present in moderate abundance and may be pale or basophilic. Immunohistochemical staining was positive for LCA, CD20, and CD79a and negative for CD3, CD5, CD30, NSE, CK, Ki67, Chromogranin and Synaptophysin. While in the hospital, the patient was managed with mechanical ventilation and symptomatic treatment. FOB and rigid Bronchoscope, debulking of tumour growths was done using electrocautery snare. The patient had mild bleeding which could be controlled easily. Airway patency on both sides was restored.Patient was continued on overnight mechanical ventilation and extubated after one day. Post extubation, patient remained alright without any respiratory distress and discharged in stable condition. Latter on patient followed in Rajiv Gandhi Cancer Hospital. He underwent PET scan of whole body, which revealed normal study. Patient was managed with chemotherapy in the form of dexamethasone, cyclophosphamide, doxorubicin, vincristine and etoposide. The patient showed good response.He is still alive after 3 years of management without any symptoms and again followed in our hospital. 
DISCUSSION
The fi rst case of endobronchial NHL was described in 1955 by Dawe et al. 4 Since then, about 50 cases have been described in the literature. 2, 3 In an autopsy study of patients with NHL (n=55), where none of the cases showed endobronchial involvement.
14 In another autopsy study, only one patient had endobronchial lesion out of 93 patients with pulmonary lymphoma. 10 These observations suggest that endobronchial involvement is very rare in patients with NHL. The involvement of tracheobronchial tree is more common in Hodgkin's lymphoma than in NHL. The most common involvement is displacement or narrowing of airway lumen by enlarged mediastinal or hilar lymph nodes 12 , followed by diffuse peribronchial infi ltrates resembling lymphangitis carcinomatosis 7 and as an endobronchial mass like in the present case. The endobronchial lesion can be solitary 6, 12 or multiple.
2, 5 The symptoms depend upon the type of involvement of intrathoracic sites and the morphological subtype of NHL. The anaplastic large cell lymphoma accounts for about 2% of all NHLs. 1 The most common extanodal site of occurrence of this type of lymphoma is the skin and its primary occurrence at other extranodal sites is rare. 3 Chest radiograph shows the features of atelectasis or obstructive pneumonitis in most of the cases with endobronchial involvement. There are different mechanisms postulated for the development of endobronchial lesions in lymphoma. These include direct invasion from adjacent mediastinal or parenchymal disease, lymphatic spread to peribronchial connective tissues or hematogenous spread.
14 In the present case, there was only primary endobronchial involvement not due to extension from the mediastinal lymph node. Bronchoscopy and endobronchial biopsy is the defi nitive investigation. Treatment depends on the extent of involvement of the tumour and the general condition of the patient. Most of the patients are managed with chemotherapy and/ or radiotherapy. The 5-year survival is over 80% and the median survival time is greater than 10 years. Poor prognostic indicators include age over 60 years, elevated B microglobulin, the lack of t(11,18) (q21,q21), persistent of disease after completion of chemotherapy.
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CONCLUSION
NHL rarely presents as an endobronchial growth and only histopathology can differentiate it from other benign and malignant endobronchial masses. 
